Antimicrobial resistance and consumption remain high in the EU/EEA and the UK, according to new ECDC data

New data released today by ECDC show that levels of antimicrobial resistance and antimicrobial consumption in the EU/EEA and the UK are still of concern, particularly in the southern and eastern parts of Europe.

The percentages of resistance to vancomycin – a last-line antibiotic – in Enterococcus faecium bloodstream infections almost doubled between 2015 and 2019. Resistance to carbapenems – another group of last-line antibiotics – remains a concern. Several countries reported carbapenem resistance percentages above 10% for Klebsiella pneumoniae, and carbapenem resistance was also common in Pseudomonas aeruginosa and Acinetobacter species, and at much higher percentages than in K. pneumoniae. As highlighted in a recent article in Eurosurveillance, national capacities for the surveillance and containment of carbapenem-resistant Acinetobacter baumannii in Europe vary considerably among countries.